promising drug for MS
November 3, 2008For patients in the early stages of multiple sclerosis, a drug usually used in leukemia treatment stops and reverses the effects of the disease.
In drug trials, Alemtuzumab has been shown to actually enlarge the brains of patients, which means that tissue lost to MS is being repaired.
Researchers are addressing side effect issues, but there is hope that the drug will be available by 2010.
